Literature DB >> 17010954

Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions.

Ann S Clark1, Beth A Costine, Brian L Jones, Megan C Kelton-Rehkopf, Sarah H Meerts, Lora L Nutbrown-Greene, Carlos A A Penatti, Donna M Porter, Paul Yang, Leslie P Henderson.   

Abstract

Illicit use of anabolic androgenic steroids (AAS) has become a prevalent health concern not only among male professional athletes, but, disturbingly, among a growing number of women and adolescent girls. Despite the increasing use of AAS among women and adolescents, few studies have focused on the effects of these steroids in females, and female adolescent subjects are particularly underrepresented. Among the hallmarks of AAS abuse are changes in reproductive behaviors. Here, we discuss work from our laboratories on the actions of AAS on the onset of puberty and sexual behaviors in female rodents, AAS interactions and sex- and age-specific effects of these steroids on neural transmission mediated by gamma-aminobutyric acid receptors within forebrain neuroendocrine control regions that may underlie AAS-induced changes in these behaviors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010954     DOI: 10.1016/j.brainres.2006.08.081

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 3.  The adolescent brain: insights from functional neuroimaging research.

Authors:  Monique Ernst; Sven C Mueller
Journal:  Dev Neurobiol       Date:  2008-05       Impact factor: 3.964

4.  Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Authors:  Marie M Onakomaiya; Donna M Porter; Joseph G Oberlander; Leslie P Henderson
Journal:  Horm Behav       Date:  2014-04-21       Impact factor: 3.587

Review 5.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

6.  Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse.

Authors:  Carlos A A Penatti; Joseph G Oberlander; Matthew C Davis; Donna M Porter; Leslie P Henderson
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

7.  Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.

Authors:  Joseph G Oberlander; Leslie P Henderson
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

8.  Enhanced fear responses in mice treated with anabolic androgenic steroids.

Authors:  Roberto Carlos Agis-Balboa; Fabio Pibiri; Marianela Nelson; Graziano Pinna
Journal:  Neuroreport       Date:  2009-04-22       Impact factor: 1.837

Review 9.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

Review 10.  Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice.

Authors:  Graziano Pinna; Roberto Carlos Agis-Balboa; Fabio Pibiri; Marianela Nelson; Alessandro Guidotti; Erminio Costa
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.